Navigation Links
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
Date:5/22/2008

people. While much of our success to date has been related to plastic surgery recovery, we have seen this quickly change with many other markets now also starting to aggressively expand. Our goal over the next few years is to expand on this growth and turn ActiPatch into a standard product that is used for almost all soft tissue injuries.

While this is a big goal we think it is one that is achievable. We believe our products are very attractive alternatives to the current therapies that are on the market today -- aspirin, Tylenol and Ibuprofen are simply not always effective and there certainly are side effects with these medications. As most everyone knows, medications such as Vioxx and Celebrex been removed from the market, except in very limited cases. These drugs, which were initially billed as virtual miracle cures turned out to be anything but miracles and, of course, the heavy-duty drugs such as Vicodin, are simply not an alternative for the vast majority of people.

We believe this situation leaves us with a huge hole in the healthcare industry relating to pain relief. We sincerely believe that ActiPatch can fill that hole and fit somewhere between the use of aspirin, Tylenol and Ibuprofen and the heavy-duty drugs that very few people should be taking. We believe we are already achieving this goal outside of the United States and as we do additional clinical trials in the United States we hope to eventually also achieve this domestically.

Price of BioElectronics Shares -- It is difficult, of course, for us to directly comment on the valuation of our stock. We believe the current stock price is based on a lot of old information. It has taken a while for BioElectronics to get off the ground relative to sales and the sales ramp is in fact happening very significantly at the current moment. We simply cannot imagine the stock price staying anywhere near the current levels as the information that we provided today moves in to the general shareh
'/>"/>

SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
2. BioElectronics Corporation Receives Major Orders From Italian Distributor
3. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
4. BioElectronics Announces Canadian Retail Product Launch
5. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
6. BioElectronics Corporation Announces Singapore and Malaysia Sales
7. Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine
8. Immunosyn Corporation Files 10-Q
9. CorVel Corporation Announces Earnings Release Webcast
10. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
11. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015  Moerae Matrix Inc. announced ... clinical trial with MMI-0100, a first-in-class inhibitor of ... for pulmonary disorders characterized by inflammation and fibrosis.  ... Kingdom , is a double-blind, two-way cross-over ... safety and tolerability of MMI-0100 when given via ...
(Date:7/28/2015)... , July 28, 2015 ... company utilizing its proprietary plant-based rhCollagen technology for ... has been appointed Senior Director of Business Development, ... http://photos.prnewswire.com/prnh/20150728/246955 ) , Ms. ... marketing, regulatory and business strategy. Prior to joining ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... state of the Biophotonics industry.The report provides a basic overview of the industry ... provided for the international markets including development trends, competitive landscape analysis, and key ...
(Date:7/27/2015)... ... July 27, 2015 , ... BlueInGreen® ... Monday. The venture will bring the world’s most efficient gas dissolution technology to ... and technologies to both the industrial and municipal markets. With offices located in ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3BlueInGreen Brings Water Treatment Technology to Florida 2
... IDM Pharma (Nasdaq:,IDMI) today announced that Jeffrey W. ... Medical Officer and Senior Vice President,of Research and Development. ... report to President and CEO Timothy P. Walbert. ... experience to,IDM Pharma and will lead the regulatory and ...
... NanoLogix, Inc. (OTC:,NNLX) is pleased to announce that ... Director of Intellectual Property. In addition, we wish ... the rapid detection of,Anthrax utilizing the NanoLogix BioNanoChannel(TM) ... experience as an intellectual property,counsel in a wide ...
... Drug Royalty LP 2 (DRC) announced,today the ... worldwide,royalty interest in PEG-INTRON for $92.5M. DRC will ... certain royalty recognition levels be met.,PEG-INTRON (peginterferon alpha-2b), ... is marketed worldwide by Schering-Plough Corporation (SGP). ...
Cached Biology Technology:IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 2IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 3IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 4IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development 5NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection 2NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection 3Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN) 2
(Date:7/21/2015)... OXFORD, Connecticut , July 21, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... the Wocket® smart wallet, announces that it has ... Tokenization System and Method. This ... that not only authorizes an account, but also ...
(Date:7/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the fourth quarter and ... the close of market. The company will host a ... p.m. PT (5:00 p.m. ET), during which management may ... the live call, analysts and investors should dial 888-455-2260 ...
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... of American Societies for Experimental Biology (FASEB) is once ... together to prevent sequestration, the automatic across-the-board budget cuts ... 1st. "These automatic spending cuts will stop science advances ... jobs," said FASEB President, Judith S. Bond, PhD. , ...
... MRI and Honorary Lecturer in Cardiovascular Medicine at The University ... the only location in the UK where the trial is ... test manufacturer, to take part in the trial as he ... heart attacks. The other trial sites are in Australia, ...
... open for the Joint Annual Meeting of the American Dairy ... meeting will take place in Indianapolis, IN from July 8 ... feature 35 symposia on topics such as animal genetics, food ... workshops, including a hands-on media training workshop on July 12. ...
Cached Biology News:Manchester patients take part in pioneering heart attack blood test trial 2
Fingerprinting II Basic software is used for analyzing fingerprint sample types (electrophoretic gels, HPLC and other chromatographic patterns, spectrophotometric and densitometric curves)....
Fingerprinting II database sharing tools is an optional module for the Fingerprinting II Basic software package that enables peer-to-peer data exchange over the internet and provides external databas...
... Fingerprinting II identification ... an optional module that ... similarity searches and identification ... library of entries of ...
...
Biology Products: